The annual Waxman Luncheon, benefiting the Samuel Waxman Cancer Research Foundation (SWCRF), took place at AVRA Madison in New York. The luncheon honored Dr. Paul Jarrod Frank for his continued support of the SWCRF mission and passion for scientific advancement, raising more than $165,000. In addition, a live fashion presentation by Max Mara featured their stunning Spring/Summer 2023 Collection. Funds will support crucial SWCRF initiatives such as the International Network on Aging and Cancer Research and the Women’s Cancer Research Program.
The Waxman Luncheon also included a live auction, silent auction, and raffle with specially curated lots featuring generous donations from companies such as Chopard, Movado, Jimmy Choo, Schiaparelli, Fendi, Arlotta Cashmere, and The Baker House 1650. Heritage Auctions were the official auctioneer.
Paul Jarrod Frank, MD, is one of the most renowned cosmetic dermatologists in the world. Recognized for his minimally invasive techniques and holistic approach to cosmetic rejuvenation and age management, he is regularly featured as a skin and aging expert in the US and international media. Since opening his private practice in 2001, Dr. Frank has been a clinical investigator, brand ambassador, and consultant for numerous international skincare, technology, and pharmaceutical companies.
PROACTIVE & POSITIVE
In the Spring of 2020, Dr. Frank launched his second book, The Pro-Aging Playbook, which emphasizes the importance of being proactive and positive in one’s attitude towards aging and guides aesthetic rejuvenation. In addition, as a board-certified dermatologist, he has lectured around the world and has authored several articles in both consumer and professional literature. Dr. Frank is a Clinical Assistant Professor of Dermatology at the Icahn School of Medicine at Mount Sinai Hospital and Chief Medical Officer at PFRANKMD by Dr. Paul Jarrod Frank, a bespoke aesthetic healthcare brand with several locations in New York, the Hamptons, and South Florida. In May of 2023, PFRANKMD Fifth Avenue reopened after an extensive expansion. With this vast physical expansion, PFRANKMD Fifth Avenue also expanded patient offerings. “My vision for PFRANKMD has always been one of multiple providers with various subspecialties offering patients an aesthetic healthcare experience for the complete pro-aging lifestyle,” says Dr. Frank. “Our patient isn’t just looking for cosmetic rejuvenation; they’re also looking for best-in-class dermatologic, functional, and integrative medical care to become their best version.”
Notable attendees at the Waxman Luncheon included Dr. Samuel Waxman, Marion Waxman, Dr. Paul Jarrod Frank, Jani Aronow Gerard, Danny Miller, Dr. Lorraine Gudas, Helen Vaysman, Nancy Litman, Lauren Silvers, Erica Linden-Fineberg, Kobi Halperin, Susan Gutfreund, Ingeborg Rennert, William Brobston, Jean Shafiroff, Ingeborg Rennert, Ariella Wertheimer, Consuelo Vanderbilt Costin, Maribel Lieberman, and Larry Scott.
DESIGNS OF THE TIMES
Max Mara, founded in 1951 by the late visionary Achille Maramotti, is one of the highest expressions of Italian luxury and style. A contemporary collection of ready-to-wear and accessories for today’s powerful women. Recognized for its timeless designs and luxurious fabrics, Max Mara is revered for the classification of the absolute coat, sharp suiting, and modern accessories. Max Mara is distributed in 2,500 locations in more than 100 countries worldwide. The Max Mara Fashion Group has nine different brands. The company remains privately held and managed by the Mariotti family.
Since 1976, SWCRF has invested more than $100 million towards collaborative, cross-institutional research, supporting more than 200 investigators around the world. The SWCRF philosophy of collaboration has led to breakthrough discoveries such as a treatment for acute promyelocytic leukemia (APL), developed in collaboration with researchers at the Shanghai Institute of Hematology that improved the survival rate to 95% (APL had an 80% fatality rate). Most recently, research funded by SWCRF led to an FDA-approved medication shown to reduce lung cancer tumors by up to 50% by targeting the KRAS protein.
For more information on Dr. Paul Jarrod Frank and PFRANKMD, visit pfrankmd.com; for information on Samuel Waxman Cancer Foundation, visit waxmancancer.org; for information on Max Mara,
visit maxmara.com